Skip to main content

Table 2 Anatomic and functional findings according to disease type

From: Safety and efficacy of Y-90 microsphere treatment in patients with primary and metastatic liver cancer: The tumor selectivity of the treatment as a function of tumor to liver flow ratio

Numbers in parentheses specify the range
Anatomic and functional findings Disease type
  HCC CRC NET All
  374.6 175.05 460.1 294.93
Tumor volume (cc) (33.2–857.8) (15.7–719.9) (15.0–984.2) (15.0–984.2)
  1592.5 2250.3 1678.5 1662.7
Liver volume (cc) (1125.9–3982.0) (898.7–2194.0) (906.0–3331.8) (898.7–3982.0)
  13.2% 8.8% 20.8% 14%
Tumor involvement (%) (2.9–30.9%) (0.9–33.6%) (1.1–48.5%) (0.9–48.5%)
  7.0 6.8 5.9 6.1
Tumor to normal liver ratio (3.9–9.2) (2.9–15.4) (3.5–11.1) (2.8–15.4)
  2.1% 4.3% 2.9% 3.3%
Lung shunt fraction (0.9–3.3%) (1.1–13.6%) (0.8–8.8%) (0.8–13.6%)